BCP
AZN icon

Blackhawk Capital Partners’s AstraZeneca AZN Stock Holding History

Blackhawk Capital Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,650
Closed -$243K – 129
2025
Q1 		$243K Sell
1,650
-268
-14% -$38.8K 0.12% 118
2024
Q4 		$251K Buy
1,918
+342
+22% +$47.9K 0.13% 112
2024
Q3 		$245K Buy
+1,576
New +$254K 0.13% 110
2018
Q4 		– Sell
-3,265
Closed -$258K – 67
2018
Q3 		$258K Buy
+3,265
New +$247K 0.36% 58

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Blackhawk Capital Partners's AZN Position: Q2 2025 in Review

Blackhawk Capital Partners sold out of AstraZeneca (AZN) in Q2 2025, closing a stake of 1,650 shares — an estimated $243K sold.

Blackhawk Capital Partners first reported a position in AZN in Q3 2018 and held it in 4 quarters. The position peaked at $258K in Q3 2018. 1,222 funds tracked by Wall St. Rank hold AZN as of Q2 2025.

  • Blackhawk Capital Partners reported no remaining AstraZeneca position as of Q2 2025 after selling out during the quarter.
  • Blackhawk Capital Partners sold 1,650 AstraZeneca shares in Q2 2025, an estimated $243K.
  • Blackhawk Capital Partners first reported a position in AstraZeneca in Q3 2018 and held it in 4 quarters.
  • Blackhawk Capital Partners's AstraZeneca position peaked at $258K in Q3 2018.
  • 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2025.

Based on Blackhawk Capital Partners's 13F filing for Q2 2025, filed 7 Aug 2025.